High Pathologic Complete Response in Her2-Positive, Early-Stage Breast Cancer to a Novel Nonanthracycline Neoadjuvant Chemotherapy

Title
High Pathologic Complete Response in Her2-Positive, Early-Stage Breast Cancer to a Novel Nonanthracycline Neoadjuvant Chemotherapy
Authors
Keywords
Breast cancer, Nab-paclitaxel, Neoadjuvant chemotherapy, Pathologic complete response, Trastuzumab
Journal
Clinical Breast Cancer
Volume 15, Issue 1, Pages 31-36
Publisher
Elsevier BV
Online
2014-06-24
DOI
10.1016/j.clbc.2014.06.004

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More